Chemical Process Development, Bristol Myers Squibb Company, One Squibb Drive, New Brunswick, New Jersey 08903, United States.
J Org Chem. 2021 Aug 6;86(15):10380-10396. doi: 10.1021/acs.joc.1c01073. Epub 2021 Jul 13.
As sp-sp disconnections gain acceptance in the medicinal chemist's toolbox, an increasing number of potential drug candidates containing this motif are moving into the pharmaceutical development pipeline. This raises a new set of questions and challenges around the novel, direct methodologies available for forging these bonds. These questions gain further importance in the context of process chemistry, where the focus is the development of scalable processes that enable the large-scale delivery of clinical supplies. In this paper, we describe our efforts to apply a wide variety of standard, photo-, and electrochemical sp-sp cross-coupling methods to a pharmaceutically relevant intermediate and optimize each through a combination of high throughput and mechanistically guided experimentation. With data regarding the performance, benefits, and limitations of these novel methods, we evaluate them against a more traditional two-step palladium-catalyzed process. This work reveals trends and similarities between these sp-sp bond-forming methods and suggests a path forward for further refinements.
随着 sp-sp 键切断技术在药物化学家工具包中得到越来越多的认可,越来越多含有这种结构的潜在药物候选物正在进入药物开发管道。这就提出了一系列围绕新型直接方法的新问题和挑战,这些方法可用于形成这些键。在工艺化学中,这些问题变得更加重要,因为工艺化学的重点是开发可扩展的工艺,以实现临床供应的大规模交付。在本文中,我们描述了我们应用各种标准的光化学和电化学 sp-sp 交叉偶联方法来合成一种药物相关中间体,并通过高通量和基于机理的实验相结合来优化每种方法的努力。通过对这些新方法的性能、优点和局限性的数据,我们将其与更传统的两步钯催化过程进行了评估。这项工作揭示了这些 sp-sp 键形成方法之间的趋势和相似性,并为进一步改进提出了一条前进的道路。